28 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
global health epidemics, such as the recent COVID-19 pandemic, which may increase the likelihood that we encounter these types of difficulties … , such as the recent COVID-19 pandemic, which may affect the conduct of a clinical trial, including by slowing potential enrollment or reducing the number
8-K
EX-10.1
tqsge5
30 May 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-10.2
8ueebqjxun5vs 6x9yc
30 May 23
Entry into a Material Definitive Agreement
7:30am
ARS
nldx 3mruq1ru
28 Apr 23
Annual report to shareholders
7:03am
S-3ASR
nirzj0 cal4d4
10 Nov 21
Automatic shelf registration
5:19pm
424B4
pws6rj 155m09bcy
21 Jun 21
Prospectus supplement with pricing info
8:08am
DRS
r5apu ifh5oepde
19 May 21
Draft registration statement
12:00am